REPORTS

Let’s Pullulate and Expand Your Business

Global Prostate Specific Antigen (Psa) Testing Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Oct 11, 2019  |  211 PAGES  |  REPORT CODE: CMM205522
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Prostate Specific Antigen (Psa) Testing is expected to grow from USD XX.0 million in 2018 to XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 11.1% during the forecast period. The research provides insights for the global Prostate Specific Antigen (Psa) Testing market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Prostate Specific Antigen (Psa) Testing industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Prostate Specific Antigen (Psa) Testing Market Segmentations:

By Players:

  • Johnson & Johnson Diagnostics

  • Roche Diagnostics

  • BioChem Pharma

  • UroLogix, Inc

  • Abbott Laboratories, Inc

  • Tosho

  • Pharmacia Delfia

  • Beckman Coulter, Inc

  • GE Helathcare

  • Bayer AG

  • Novartis Pharma AG

  • Bristol - Myers Squibb Company

  • GlaxoSmithKline, plc

  • Olympus

  • AstraZeneca plc

By Types:

  • Free Prostate Specific Antigen Test

  • Complex Prostate Specific Antigen Test

  • Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test

By End-User:

  • End-Users 1

  • End-Users 2

  • End-Users 3

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Prostate Specific Antigen (Psa) Testing Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Prostate Specific Antigen (Psa) Testing Market Share by Types

    • 1.3.2 Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of Free Prostate Specific Antigen Test from 2014 to 2026

    • 1.3.3 Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of Complex Prostate Specific Antigen Test from 2014 to 2026

    • 1.3.4 Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Prostate Specific Antigen (Psa) Testing Market Share by End-Users

    • 1.4.2 Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of End-User 1 from 2014 to 2026

    • 1.4.3 Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of End-User 2 from 2014 to 2026

    • 1.4.4 Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of End-User 3 from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Prostate Specific Antigen (Psa) Testing Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Prostate Specific Antigen (Psa) Testing by Major Types

    • 3.4.1 Market Size and Growth Rate of Free Prostate Specific Antigen Test

    • 3.4.2 Market Size and Growth Rate of Complex Prostate Specific Antigen Test

    • 3.4.3 Market Size and Growth Rate of Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test

4 Segmentation of Prostate Specific Antigen (Psa) Testing Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Prostate Specific Antigen (Psa) Testing by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Prostate Specific Antigen (Psa) Testing for End-Users 1

    • 4.4.2 Market Size and Growth Rate of Prostate Specific Antigen (Psa) Testing for End-Users 2

    • 4.4.3 Market Size and Growth Rate of Prostate Specific Antigen (Psa) Testing for End-Users 3

5 Market Analysis by Major Regions

  • 5.1 Global Prostate Specific Antigen (Psa) Testing Production Analysis by Major Regions

  • 5.2 Global Prostate Specific Antigen (Psa) Testing Consumption Analysis by Major Regions

  • 5.3 Global Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis

6 Product Commodity of Prostate Specific Antigen (Psa) Testing Market in Major Countries

  • 6.1 Top 5 Export Countries in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Prostate Specific Antigen (Psa) Testing Landscape Analysis

  • 7.1 North America Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Types

  • 7.2 North America Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major End-Users

  • 7.3 North America Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Countries

    • 7.3.1 United States Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 7.3.2 Canada Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 7.3.3 Mexico Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

8 Europe Prostate Specific Antigen (Psa) Testing Landscape Analysis

  • 8.1 Europe Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Types

  • 8.2 Europe Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major End-Users

  • 8.3 Europe Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Countries

    • 8.3.1 Germany Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.2 UK Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.3 France Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.4 Italy Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.6 Spain Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.7 Belgium Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.8 Poland Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.9 Russia Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 8.3.10 Turkey Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

9 Asia Pacific Prostate Specific Antigen (Psa) Testing Landscape Analysis

  • 9.1 Asia Pacific Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Types

  • 9.2 Asia Pacific Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Countries

    • 9.3.1 China Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 9.3.2 Japan Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 9.3.4 India Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 9.3.6 South Korea Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

10 Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 10.3.2 Brazil Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 10.3.3 Nigeria Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

    • 10.3.4 South Africa Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate 

    • 10.3.5 Argentina Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Johnson & Johnson Diagnostics

    • 11.1.1 Johnson & Johnson Diagnostics Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Roche Diagnostics

    • 11.2.1 Roche Diagnostics Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 BioChem Pharma

    • 11.3.1 BioChem Pharma Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 UroLogix, Inc

    • 11.4.1 UroLogix, Inc Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Abbott Laboratories, Inc

    • 11.5.1 Abbott Laboratories, Inc Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Tosho

    • 11.6.1 Tosho Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Pharmacia Delfia

    • 11.7.1 Pharmacia Delfia Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Beckman Coulter, Inc

    • 11.8.1 Beckman Coulter, Inc Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 GE Helathcare

    • 11.9.1 GE Helathcare Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Bayer AG

    • 11.10.1 Bayer AG Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Novartis Pharma AG

    • 11.11.1 Novartis Pharma AG Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Bristol - Myers Squibb Company

    • 11.12.1 Bristol - Myers Squibb Company Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 GlaxoSmithKline, plc

    • 11.13.1 GlaxoSmithKline, plc Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Olympus

    • 11.14.1 Olympus Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 AstraZeneca plc

    • 11.15.1 AstraZeneca plc Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 103 Figures and 164 Tables)

  • Figure Product Picture

  • Figure Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of Free Prostate Specific Antigen Test from 2014 to 2026

  • Figure Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of Complex Prostate Specific Antigen Test from 2014 to 2026

  • Figure Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of End-User 1 from 2014 to 2026

  • Figure Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of End-User 2 from 2014 to 2026

  • Figure Global Prostate Specific Antigen (Psa) Testing Market Size and Growth Rate of End-User 3 from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Prostate Specific Antigen (Psa) Testing Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Prostate Specific Antigen (Psa) Testing Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Prostate Specific Antigen (Psa) Testing

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Prostate Specific Antigen (Psa) Testing by Different Types from 2014 to 2026

  • Table Consumption Share of Prostate Specific Antigen (Psa) Testing by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Free Prostate Specific Antigen Test

  • Figure Market Size and Growth Rate of Complex Prostate Specific Antigen Test

  • Figure Market Size and Growth Rate of Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Prostate Specific Antigen (Psa) Testing by Different End-Users from 2014 to 2026

  • Table Consumption Share of Prostate Specific Antigen (Psa) Testing by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of End-User 1

  • Figure Market Size and Growth Rate of End-User 2

  • Figure Market Size and Growth Rate of End-User 3

  • Table Global Prostate Specific Antigen (Psa) Testing Production by Major Regions

  • Table Global Prostate Specific Antigen (Psa) Testing Production Share by Major Regions

  • Figure Global Prostate Specific Antigen (Psa) Testing Production Share by Major Regions in 2014

  • Figure Global Prostate Specific Antigen (Psa) Testing Production Share by Major Regions in 2018

  • Figure Global Prostate Specific Antigen (Psa) Testing Production Share by Major Regions in 2026

  • Table Global Prostate Specific Antigen (Psa) Testing Consumption by Major Regions

  • Table Global Prostate Specific Antigen (Psa) Testing Consumption Share by Major Regions

  • Figure Global Prostate Specific Antigen (Psa) Testing Consumption Share by Major Regions in 2014

  • Figure Global Prostate Specific Antigen (Psa) Testing Consumption Share by Major Regions in 2018

  • Figure Global Prostate Specific Antigen (Psa) Testing Consumption Share by Major Regions in 2026

  • Table North America Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis

  • Table Europe Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Prostate Specific Antigen (Psa) Testing market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Prostate Specific Antigen (Psa) Testing Consumption by Types from 2014 to 2026

  • Table North America Prostate Specific Antigen (Psa) Testing Consumption Share by Types from 2014 to 2026

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2014

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2018

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2026

  • Table North America Prostate Specific Antigen (Psa) Testing Consumption by End-Users from 2014 to 2026

  • Table North America Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users from 2014 to 2026

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2014

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2018

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2026

  • Table North America Prostate Specific Antigen (Psa) Testing Consumption by Major Countries from 2014 to 2026

  • Table North America Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2014

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2018

  • Figure North America Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2026

  • Figure United States Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Prostate Specific Antigen (Psa) Testing Consumption by Types from 2014 to 2026

  • Table Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Types from 2014 to 2026

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2014

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2018

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2026

  • Table Europe Prostate Specific Antigen (Psa) Testing Consumption by End-Users from 2014 to 2026

  • Table Europe Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2014

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2018

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2026

  • Table Europe Prostate Specific Antigen (Psa) Testing Consumption by Major Countries from 2014 to 2026

  • Table Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2014

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2018

  • Figure Europe Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2026

  • Figure Germany Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure France Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption by Types from 2014 to 2026

  • Table Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2014

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2018

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2026

  • Table Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2014

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2018

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2026

  • Table Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2026

  • Figure China Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandProstate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure India Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Prostate Specific Antigen (Psa) Testing Consumption Share by Major Countries in 2026

  • Figure GCC Countries Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Prostate Specific Antigen (Psa) Testing Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Johnson & Johnson Diagnostics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Diagnostics

  • Figure Sales and Growth Rate Analysis of Johnson & Johnson Diagnostics

  • Figure Revenue and Market Share Analysis of Johnson & Johnson Diagnostics

  • Table Product and Service Introduction of Johnson & Johnson Diagnostics

  • Table Company Profile and Development Status of Roche Diagnostics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics

  • Figure Sales and Growth Rate Analysis of Roche Diagnostics

  • Figure Revenue and Market Share Analysis of Roche Diagnostics

  • Table Product and Service Introduction of Roche Diagnostics

  • Table Company Profile and Development Status of BioChem Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioChem Pharma

  • Figure Sales and Growth Rate Analysis of BioChem Pharma

  • Figure Revenue and Market Share Analysis of BioChem Pharma

  • Table Product and Service Introduction of BioChem Pharma

  • Table Company Profile and Development Status of UroLogix, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UroLogix, Inc

  • Figure Sales and Growth Rate Analysis of UroLogix, Inc

  • Figure Revenue and Market Share Analysis of UroLogix, Inc

  • Table Product and Service Introduction of UroLogix, Inc

  • Table Company Profile and Development Status of Abbott Laboratories, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories, Inc

  • Figure Sales and Growth Rate Analysis of Abbott Laboratories, Inc

  • Figure Revenue and Market Share Analysis of Abbott Laboratories, Inc

  • Table Product and Service Introduction of Abbott Laboratories, Inc

  • Table Company Profile and Development Status of Tosho

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tosho

  • Figure Sales and Growth Rate Analysis of Tosho

  • Figure Revenue and Market Share Analysis of Tosho

  • Table Product and Service Introduction of Tosho

  • Table Company Profile and Development Status of Pharmacia Delfia

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmacia Delfia

  • Figure Sales and Growth Rate Analysis of Pharmacia Delfia

  • Figure Revenue and Market Share Analysis of Pharmacia Delfia

  • Table Product and Service Introduction of Pharmacia Delfia

  • Table Company Profile and Development Status of Beckman Coulter, Inc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beckman Coulter, Inc

  • Figure Sales and Growth Rate Analysis of Beckman Coulter, Inc

  • Figure Revenue and Market Share Analysis of Beckman Coulter, Inc

  • Table Product and Service Introduction of Beckman Coulter, Inc

  • Table Company Profile and Development Status of GE Helathcare

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Helathcare

  • Figure Sales and Growth Rate Analysis of GE Helathcare

  • Figure Revenue and Market Share Analysis of GE Helathcare

  • Table Product and Service Introduction of GE Helathcare

  • Table Company Profile and Development Status of Bayer AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

  • Figure Sales and Growth Rate Analysis of Bayer AG

  • Figure Revenue and Market Share Analysis of Bayer AG

  • Table Product and Service Introduction of Bayer AG

  • Table Company Profile and Development Status of Novartis Pharma AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Pharma AG

  • Figure Sales and Growth Rate Analysis of Novartis Pharma AG

  • Figure Revenue and Market Share Analysis of Novartis Pharma AG

  • Table Product and Service Introduction of Novartis Pharma AG

  • Table Company Profile and Development Status of Bristol - Myers Squibb Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol - Myers Squibb Company

  • Figure Sales and Growth Rate Analysis of Bristol - Myers Squibb Company

  • Figure Revenue and Market Share Analysis of Bristol - Myers Squibb Company

  • Table Product and Service Introduction of Bristol - Myers Squibb Company

  • Table Company Profile and Development Status of GlaxoSmithKline, plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline, plc

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline, plc

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline, plc

  • Table Product and Service Introduction of GlaxoSmithKline, plc

  • Table Company Profile and Development Status of Olympus

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Olympus

  • Figure Sales and Growth Rate Analysis of Olympus

  • Figure Revenue and Market Share Analysis of Olympus

  • Table Product and Service Introduction of Olympus

  • Table Company Profile and Development Status of AstraZeneca plc

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca plc

  • Figure Sales and Growth Rate Analysis of AstraZeneca plc

  • Figure Revenue and Market Share Analysis of AstraZeneca plc

  • Table Product and Service Introduction of AstraZeneca plc


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top